Dynavax to Present at the Stifel 2019 Healthcare Conference
08 November 2019 - 8:05AM
Dynavax Technologies Corporation (NASDAQ: DVAX), a
biopharmaceutical company focused on developing and commercializing
novel vaccines, today announced that Ryan Spencer, Co-President,
will present at the Stifel 2019 Healthcare Conference on Wednesday,
November 20, at 9:45 a. m. E.T.
The presentation will be webcast and may be
accessed at the “Events & Presentations” section of the
Company’s website at
http://investors.dynavax.com/events-presentations.
About DynavaxDynavax is a
commercial stage biopharmaceutical company developing and
commercializing novel vaccines. The Company launched its first
commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant),
Adjuvanted], in February 2018, following U.S. FDA approval for
prevention of infection caused by all known subtypes of hepatitis B
virus in adults age 18 years and older. For more information, visit
www.dynavax.com and follow the company on LinkedIn.
Contacts:
Nicole Arndtnarndt@dynavax.com510-665-7264
Derek Cole, President Investor Relations
Advisory Solutionsderek.cole@IRadvisory.com
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Apr 2024 to May 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From May 2023 to May 2024